BE FAST vs. FAST: A Study in the General Public. (BFF)

BE FAST vs. FAST: A Randomized Trial Comparing Retention of Stroke Symptoms Between Two Mnemonics in the General Public.

A randomized, blinded prospective study assessing retention of two stroke mnemonics (BE FAST and FAST) in the general public after receiving brief stroke education. Participants were randomized to one of two education arms and retention was tested at 3 different time intervals.

Study Overview

• Status: Completed
• Conditions: Stroke
• Intervention / Treatment: Other: BE-FAST; Other: FAST

• Study Type: Interventional
• Enrollment (Actual): 174
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Wisconsin
    • Green Bay, Wisconsin, United States, 54311
      • Aurora BayCare Medical Center

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

1. Subject 18 years of age or older
2. Subject speaks English (Does not need interpreter)
3. Subject able to read English
4. Subject willing to provide a phone number for future follow up
5. Subject willing and agreeable to up to 2 phone follow up calls
6. Subject willing to provide verbal consent to participate

Exclusion Criteria:

1. Subject non-English speaking (needs interpreter)
2. Subject has visual or hearing impairment
3. Subject has history of Dementia or a learning disability
4. Subject had stroke education within the past year
5. Subject had a previous stroke

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Triple

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: BE-FAST	Other: BE-FAST; This intervention includes those randomized to the education with the BE-FAST mnemonic.
Other: FAST	Other: FAST; This intervention includes those randomized to the education with the FAST mnemonic.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Recall Visit 1	Number/percentage of participants in the FAST and BE-FAST groups at Visit 1 who accurately recall the mnemonic they were taught during the education session.	60 minutes

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Retention Rate Symptom	Retention rate of each stroke symptom in the mnemonic	30 days
Recall Rate Symptom	Total number of stroke symptoms that were accurately recalled by the participants	30 days
Recall Participant Percentage	Number/percentage of participants able to recall all the symptoms included in the mnemonic	30 days
Patrial Recall Participant Percentage	Number/percentage of participants able to recall 2 or more symptoms of the FAST mnemonic or 3 or more of the BE-FAST mnemonic.	30 days
Common Recall Participant Percentage	Number/percentage of participants able to recall the more common symptoms of each mnemonic (Facial weakness, arm weakness and speech difficulties)	30 days
Retention per Professional Background	Compare participants with medical vs. non-medical professional backgrounds and explore whether there are any group differences in retention rates.	30 days

Collaborators and Investigators

• Sponsor: Wake Forest University Health Sciences
• Collaborators: Aurora BayCare Medical Center; BayCare Health System
• Investigators: Principal Investigator: Ziad Darkhabani, MD, Aurora Baycare

Study record dates

Study Major Dates

• Study Start (Actual): November 20, 2021
• Primary Completion (Actual): May 18, 2023
• Study Completion (Actual): June 23, 2023

Study Registration Dates

• First Submitted: November 13, 2023
• First Submitted That Met QC Criteria: November 21, 2023
• First Posted (Actual): November 30, 2023

Study Record Updates

• Last Update Posted (Actual): October 3, 2024
• Last Update Submitted That Met QC Criteria: October 1, 2024
• Last Verified: November 1, 2023

More Information

Terms related to this study

• Keywords: FAST; BE-FAST
• Additional Relevant MeSH Terms: Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Stroke
• Other Study ID Numbers: 19-807

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No